High Ceramide Content Liposomes with in Vivo Antitumor Activity

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3663-3669

  Shabbits, Jennifer A ^a,b   Mayer, Lawrence D ^a,b,c  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Celator Technologies Inc   (Canada)

Author keywords

Antitumor; Apoptosis; Bioactive lipid; Ceramide; Liposomes

Indexed keywords

CERAMIDE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; FEMALE; IN VIVO STUDY; LIFESPAN; LIGHT SCATTERING; LIPID BILAYER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASCITES; CELL LINE, TUMOR; CERAMIDES; FEMALE; LIPID BILAYERS; LIPOSOMES; MACROPHAGES; MICE; MICE, INBRED BALB C;

EID: 0344011013     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kolesnick R, and Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328, 1994.
2. Obeid LM and Hannun YA: Ceramide: a stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58: 191-198, 1995.
3. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley, RT, Voss KA and Wang E: Sphingolipids - the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142: 208-225, 1997.
4. Kinnunen PK and Holopainen JM: Sphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis? Trends Cardiovasc Med 12: 37-42, 2002.
5. Feuerstein GZ: Apoptosis in cardiac diseasesnew opportunities for novel therapeutics for heart diseases. Cardiovasc Drugs Ther 13: 289-294, 1999.
6. Feuerstein GZ and Young PR: Apoptosis in cardiac diseases: stress- and mitogen-activated signaling pathways. Cardiovasc Res 45: 560-509, 2000.
7. Levade T, Auge N, Veldman RJ, Cuvillier O, Negre-Salvayre A and Salvayre R: Sphingolipid mediators in cardiovascular cell biology and pathology. Circ Res 89: 957-968, 2001.
8. Listenberger LL and Schaffer JE: Mechanisms of lipoapoptosis: implications for human heart disease. Trends Cardiovasc Med 12: 134-8, 2002.
9. Charles R, Sandirasegarane L, Yun J, Bourbon N, Wilson R, Rothstein RP, Levison SW and Kester M: Ceramide-coated balloon catheters limit neointimal hyperplasia after stretch injury in carotid arteries. Circ Res 87: 282-288, 2000.
10. Lavie Y, Cao H, Bursten SL, Giuliano AE and Cabot MC: Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 271: 19530-19536, 1996.
11. Furuya K, Ginis I, Takeda H, Chen Y and Hallenbeck JM: Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metabol 21: 226-232, 2001.
12. Modrak DE, Lew W, Goldenberg DM and Blumenthal R: Sphingomyelin potentiates chemotherapy of human cancer xenografts. Biochem Biophys Res Commun 268: 603-606, 2000.
13. Modrak DE, Rodriguez MD, Goldenberg DM, Lew W and Blumenthal RD: Sphingomyelin enhances chemotherapy efficacy and increases apoptosis in human colonic tumor xenografts. Int J Oncol 20: 379-384, 2002.
14. Nicholson KM, Quinn DM, Kellett GL and Warr JR: Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase. Br J Cancer 81: 423-430, 1999.
15. Sietsma H, Veldman RJ, Kolk D, Ausema B, Nijhof W, Kamps W, Vellenga E and Kok JW: 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine. Clin Cancer Res 6: 942-948, 2000.
16. Shabbits JA and Mayer LD: P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs. Molecul Canc Therap 1: 205-213, 2002.
17. Shabbits JA and Mayer LD: Intracellular delivery of ceramide lipids via liposomes enhances apoptosis in vitro. Biochim Biophys Acta 1612(1): 98-106, 2003.
18. Derksen JT, Morselt HW and Scherphof GL: Processing of different liposome markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim Biophys Acta 931: 33-40, 1987.
19. Almgren M, Edwards K and Karlsson G: Cryo transmission electron microscopy of liposomes and related structures. Colloids and Surfaces 174: 3-21, 2000.
20. Carrer DC and Maggio B: Transduction to self-assembly of molecular geometry and local interactions in mixtures of ceramides and ganglioside GM1. Biochim Biophys Acta 1514: 87-99, 2001.
21. Cullis P, Fenske D and Hope M: Physical properties and functional roles of lipids in membranes. In: Biochemistry of Lipids, Lipoproteins and Membranes. (Vance, DE and Vance, JE, Eds.), Elsevier Science pp 1-33, 1996.
22. Slepushkin VA, Simoes S, Dazin P, Newman MS, Guo LS, Pedroso de Lima MC and Duzgunes N: Sterically stabilized pH-sensitive liposomes. Intracellular delivery of aqueous contents and prolonged circulation in vivo. J Biol Chem 272: 2382-2388, 1997.
23. Hafez I M and Cullis PR: Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior. Biochim Biophys Acta 1463: 107-114, 2000.
24. Cullis PR, Hope MJ, Bally MB, Madden TD, Mayer LD and Janoff AS: Liposomes as Pharmaceuticals. In: Liposomes: From Biophysics to Therapeutics. (Ostro, M.J, Ed.), Marcel Dekker, Inc., New York, pp 39-72 (1987).
25. Chiu GN, Bally MB and Mayer LD: Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). Biochim Biophys Acta 1510: 56-69, 2001.
26. Chiu GN, Bally MB and Mayer LD: Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids. Biochim Biophys Acta 1560: 37-50, 2002.
27. Shabbits JA, Chiu GN and Mayer LD: Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems. J Control Release 84: 161-170, 2002.
28. Bally MB, Masin D, Nayar R, Cullis, PR and Mayer L D: Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice. Cancer Chemother Pharmacol 34: 137-146, 1994.